Barclays PLC Grows Stock Holdings in Herbalife Ltd. (NYSE:HLF)

Barclays PLC boosted its stake in shares of Herbalife Ltd. (NYSE:HLF) by 347.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 161,426 shares of the company’s stock after buying an additional 125,311 shares during the quarter. Barclays PLC owned 0.16% of Herbalife worth $1,160,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Carolina Wealth Advisors LLC acquired a new stake in Herbalife in the 3rd quarter valued at about $78,000. Algert Global LLC lifted its holdings in shares of Herbalife by 98.9% in the second quarter. Algert Global LLC now owns 20,173 shares of the company’s stock valued at $210,000 after purchasing an additional 10,033 shares in the last quarter. Prospera Financial Services Inc acquired a new stake in shares of Herbalife in the third quarter valued at approximately $154,000. Intech Investment Management LLC purchased a new position in shares of Herbalife during the 3rd quarter worth approximately $199,000. Finally, Townsquare Capital LLC acquired a new position in shares of Herbalife during the 3rd quarter worth approximately $237,000.

Herbalife Price Performance

Shares of HLF stock opened at $6.49 on Tuesday. The company’s fifty day moving average price is $7.48 and its two-hundred day moving average price is $8.23. The firm has a market capitalization of $654.14 million, a P/E ratio of 7.64, a P/E/G ratio of 0.26 and a beta of 1.18. Herbalife Ltd. has a 12 month low of $6.21 and a 12 month high of $13.30.

Herbalife (NYSE:HLF) last announced its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.38. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.23 billion. On average, sell-side analysts anticipate that Herbalife Ltd. will post 1.51 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on HLF. Citigroup dropped their price target on Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, October 25th. DA Davidson cut their target price on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating for the company in a research note on Thursday, October 31st. Mizuho raised their price target on shares of Herbalife from $8.00 to $9.00 and gave the stock a “neutral” rating in a research note on Friday, November 1st. B. Riley cut their price objective on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, October 31st. Finally, StockNews.com upgraded shares of Herbalife from a “hold” rating to a “buy” rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $9.90.

Herbalife Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.